Effect of dexmedetomidine on preventing postoperative agitation in children: a meta-analysis

Juan Ni1, Jiafu Wei2, Yusheng Yao3

  • 1Department of Anaesthesiology, West China Second University Hospital, Key Laboratory of Birth Defects and Related Diseases of Women and Children, Sichuan University, Chengdu, Sichuan, China.

Plos One
|May 22, 2015
PubMed

Insights

Dexmedetomidine effectively prevents emergence agitation (EA) in children, reducing severe pain and the need for rescue drugs. While it slightly prolongs eye-opening and PACU discharge times, it is more beneficial than propofol or fentanyl for preventing EA.

Area of Science:

  • Anesthesiology
  • Pediatric Medicine
  • Pharmacology

Background:

  • Emergence agitation (EA) is a frequent postoperative complication in pediatric patients.
  • Understanding effective pharmacological interventions for EA is crucial for improving pediatric surgical outcomes.

Purpose of the Study:

  • To conduct a meta-analysis evaluating the efficacy of dexmedetomidine in preventing postoperative emergence agitation in children.
  • To compare dexmedetomidine with placebo and other anesthetic agents for EA prevention.

Main Methods:

  • Systematic search of major databases (Cochrane, MEDLINE, EMBASE) for randomized controlled trials.
  • Inclusion of trials assessing dexmedetomidine's effect on EA incidence, rescue medication use, and recovery parameters (eye-opening, extubation, PACU discharge).

Main Results:

  • Analysis of 19 trials (1608 patients) demonstrated that intravenous dexmedetomidine significantly reduced EA incidence compared to placebo (RR 0.34).
  • Dexmedetomidine also decreased severe pain and the need for rescue drugs, but slightly increased time to eye-open and PACU discharge.
  • Compared to other agents, dexmedetomidine showed superior EA prevention over fentanyl and propofol.

Conclusions:

  • Dexmedetomidine is an effective agent for preventing emergence agitation in children.
  • It offers benefits in reducing pain and rescue drug requirements, despite minor increases in recovery times.
  • Dexmedetomidine presents a favorable option for EA prevention, particularly when compared to propofol and fentanyl.
Abstract

Related Concept Videos

Parenteral Anesthetics: Overview01:24

Parenteral Anesthetics: Overview

Intravenous anesthetics are drugs administered parenterally to induce anesthesia or sedation. Propofol is a widely used agent formulated as a 1% emulsion in soybean oil, glycerol, and egg phosphatide. It induces rapid anesthesia primarily due to its rapid distribution from the bloodstream to target tissues and is metabolized in the liver. However, it can cause significant pain on injection and hypertriglyceridemia. Fospropofol, a water-based prodrug of propofol, lacks these adverse effects.
955
Skeletal Muscle Relaxants: Adverse Effects01:21

Skeletal Muscle Relaxants: Adverse Effects

Skeletal muscle relaxants are widely used for muscle paralysis and relieving pain following any muscle injury or stiffness. However, depending on the drug type, they can have adverse effects that range from mild to severe. Usually, nondepolarizing neuromuscular blockers have minimal side effects. For example, drugs like d-tubocurarine, cisatracurium, and rocuronium cause hypotension, whereas drugs like baclofen, when stopped abruptly, can lead to the recurrence of spastic conditions.
Unlike...
1.1K
Sedatives and Hypnotics Drugs: Miscellaneous Agents01:17

Sedatives and Hypnotics Drugs: Miscellaneous Agents

Sedatives and hypnotics encompass a wide range of substances, each with its unique mechanism of action, uses, and potential adverse effects.
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
920
Depolarizing Blockers: Pharmocokinetics01:19

Depolarizing Blockers: Pharmocokinetics

Depolarizing blockers are administered through intravenous injection. Succinylcholine is the most common choice of depolarizing blockers in emergency clinical practices. Although they have a rapid onset, they readily diffuse away from the motor end plate into the extracellular fluid. They are metabolized by enzymes such as liver butyrylcholinesterase and plasma pseudocholinesterases. This produces a short duration of action, typically 5-10 minutes long, unlike nondepolarizing blockers, which...
732
Skeletal Muscle Relaxants: Therapeutic Uses01:31

Skeletal Muscle Relaxants: Therapeutic Uses

Skeletal muscle relaxants are used to relax muscle tone and alleviate painful muscle contractions. However, the choice of skeletal muscle relaxants depends on the duration of the surgical procedure in order to minimize potential side effects. Skeletal muscle relaxants like neuromuscular blocking agents [NMBAs] are commonly employed as adjuvants alongside general anesthetics in clinical settings. NMBAs are also used to maintain controlled ventilation during surgery of the larynx or pharynx...
1.2K
Chemotherapy-Induced Nausea and Vomiting: Dopamine Receptor Antagonists01:29

Chemotherapy-Induced Nausea and Vomiting: Dopamine Receptor Antagonists

Dopamine receptor antagonists, also known as antipsychotic agents, are critical in managing chemotherapy-induced vomiting. These antiemetic agents block dopamine receptors in the chemoreceptor trigger zone (CTZ), inhibiting signal transmission to the vomiting center. Antipsychotic agents encompass phenothiazines (PTZ), butyrophenones, benzamides, and thienobenzodiazepines (Zyprexa), which are utilized for their antiemetic and sedative properties.
Phenothiazines, such as prochlorperazine...
1.1K